The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs
Artikel i vetenskaplig tidskrift, 2022

The gut microbiota plays a fundamental role in human nutrition and metabolism and may have direct implications for type 2 diabetes and associated preconditions. An improved understanding of relations between human gut microbiota and glucose metabolism could lead to novel opportunities for type 2 diabetes prevention, but human observational studies reporting on such findings have not been extensively reviewed. Here, we review the literature on associations between gut microbiota and markers and stages of glucose dysregulation and insulin resistance in healthy adults and in adults with metabolic disease and risk factors. We present the current evidence for identified key bacteria and their potential roles in glucose metabolism independent of overweight, obesity, and metabolic drugs. We provide support for SCFAs mediating such effects and discuss the role of diet, as well as metabolites derived from diet and gut microbiota interactions. From 5983 initially identified PubMed records, 45 original studies were eligible and reviewed. alpha Diversity and 45 bacterial taxa were associated with selected outcomes. Six taxa were most frequently associated with glucose metabolism: Akkermansia muciniphila, Bifidobacterium longum, Clostridium leptum group, Faecalibacterium prausnitzii, and Faecalibacterium (inversely associated) and Dorea (directly associated). For Dorea and A. muciniphila, associations were independent of metabolic drugs and body measures. For A. muciniphila and F. prausnitzii, limited evidence supported SCFA mediation of potential effects on glucose metabolism. We conclude that observational studies applying metagenomics sequencing to identify species-level relations are warranted, as are studies accounting for confounding factors and investigating SCFA and postprandial glucose metabolism. Such advances in the field will, together with mechanistic and prospective studies and investigations into diet-gut microbiota interactions, have the potential to bring critical insight into roles of gut microbiota and microbial metabolites in human glucose metabolism and to contribute toward the development of novel prevention strategies for type 2 diabetes, including precision nutrition.

insulin resistance

microbial metabolites

type 2 diabetes prevention

short-chain fatty acids

precision nutrition

humans

diet-gut microbiota interactions

prediabetes

gut microbiota

glucose metabolism

Författare

Marie Palmnäs

Chalmers, Biologi och bioteknik, Livsmedelsvetenskap

Giuseppina Costabile

Universita degli Studi di Napoli Federico II

Claudia Vetrani

Universita degli Studi di Napoli Federico II

Sebastian Åberg

Chalmers, Biologi och bioteknik, Livsmedelsvetenskap

Yommine Hjalmarsson

Chalmers, Vetenskapens kommunikation och lärande, Lärande och lärandemiljöer

Johan Dicksved

Sveriges lantbruksuniversitet (SLU)

Gabriele Riccardi

Universita degli Studi di Napoli Federico II

Rikard Landberg

Chalmers, Biologi och bioteknik, Livsmedelsvetenskap

American Journal of Clinical Nutrition

0002-9165 (ISSN) 19383207 (eISSN)

Vol. 116 4 862-874

Ämneskategorier

Endokrinologi och diabetes

Farmakologi och toxikologi

Näringslära

DOI

10.1093/ajcn/nqac217

PubMed

36026526

Mer information

Senast uppdaterat

2023-10-27